In its July 27 print edition, Time magazine ran a full-page color ad for smokeless tobacco. But what really got our attention were all the drug ads, which continue week after week, and presumably keep the faltering publication alive. The biggest ad, an inside-front-cover three-page spread, was for Xeljanz (tofacitinib citrate), which is aimed at people with rheumatoid arthritis. As …